Orchestra BioMed Holdings (OBIO) stock, explained like you're 5

Is Orchestra BioMed Holdings a small, medium or large cap company?

No. Orchestra BioMed Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 358 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Orchestra BioMed Holdings makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves OBIO stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation (Seeking Alpha)
• OBIO Feb 2027 5.000 put (OBIO270219P00005000) interactive stock chart (Yahoo Finance UK)
• $OBIO stock is down 9% today. Here's what we see in our data. (Quiver Quantitative)
• A pacemaker therapy trial for hard to control blood pressure enrolled 330 people (Stock Titan)
• Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report (Simply Wall Street)

Key terms to know before you follow OBIO

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility